Home / Central Data Catalog / FRESH-PEF148-EN
central

An Observational study to assess the burden of illness in prostate cancer patients with low to moderate risk of progression

France, Germany, Italy...and 2 more, 2009 - 2011
Reference ID
FRESH-PEF148-en
Producer(s)
Christel;LECLERC-ZWIRN
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Feb 18, 2026
Last modified
Feb 18, 2026
Page views
57
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Data Access
  • Contacts

    • Identification

    Survey ID number

    FRESH-PEF148-en
    Title

    An Observational study to assess the burden of illness in prostate cancer patients with low to moderate risk of progression
    Abbreviation or Acronym

    CAPTURE
    Country
    Name Country code
    France fr
    Germany de
    Italy it
    Spain es
    Sweden se
    Kind of Data

    ['Clinical data','Participant-reported health data']
    Unit of Analysis

    Individuals

    Scope

    Topics
    Topic Vocabulary
    Oncology health theme
    Andrology and urology health theme
    Keywords
    prostate cancer

    Coverage

    Universe

    {"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}}],"level_age_clusion_I":[{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"1. Demography: Males aged between 50-75 years. 2. Disease characteristics: Gleason score ≤7, PSA ≤20, and clinical staging T1c-T2b (according to D’Amico criteria of low-intermediate risk [D'Amico, 1998]). 3. Informed consent: Subject is willing and able to provide written informed consent. 4. Literacy: Able to read and write in order to complete the study questionnaires.","clusion_E":""}

    Producers and sponsors

    Primary investigators
    Name
    Christel;LECLERC-ZWIRN
    Producers
    Name Role
    GLAXOSMITHKLINE (FRANCE) sponsor
    Funding Agency/Sponsor
    Name
    GLAXOSMITHKLINE (FRANCE)

    Study authorization

    Agency
    Agency name
    CNIL

    Sampling

    Sample frame

    Unit Type

    ['Through organizations (health services or institutions, schools, businesses, etc.)','Through independent healthcare practitioners']
    Sampling Procedure

    ['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']

    Survey instrument

    Questionnaires

    Access on specific project only
    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    2009-01-01 2011-01-01
    Mode of data collection
    • {"concept":{"vocabURI":"Interview","vocab":"CESSDA"},"value":"Interview with the participant (including clinical)"}

    Study activities

    Study activities
    Type
    primary evaluation
    Description
    Health care consumption and services Quality of life/health perception

    Data Access

    Availability Status

    {"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}

    Contacts

    Contacts
    Name Email
    Christel;LECLERC-ZWIRN christel.c.leclerc-zwirn@gsk.com
    Back to Catalog